Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytodyn Inc (OP: CYDY ) 0.1391 -0.0008 (-0.57%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,263,736 Open 0.1391 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1399 Today's Range 0.1360 - 0.1439 52wk Range 0.1275 - 0.4180 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CytoDyn Announces Settlement with Amarex Clinical Research LLC July 09, 2024 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024 June 27, 2024 From CytoDyn Inc. Via GlobeNewswire Performance YTD -29.39% -29.39% 1 Month -0.86% -0.86% 3 Month -12.24% -12.24% 6 Month -36.63% -36.63% 1 Year -49.40% -49.40% More News Read More CytoDyn to Host Webcast to Provide Company Update May 28, 2024 From CytoDyn Inc. Via GlobeNewswire May 2024 Letter to Shareholders May 16, 2024 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces FDA Has Lifted Clinical Hold February 29, 2024 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma February 01, 2024 From CytoDyn Inc. Via GlobeNewswire CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO January 29, 2024 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces Webcast to Provide Company Update December 07, 2023 From CytoDyn Inc. Via GlobeNewswire CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO November 21, 2023 From CytoDyn Inc. Via GlobeNewswire November 2023 Letter to Shareholders November 03, 2023 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces Company Updates and Investment Community Update Webcast July 11, 2023 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces President Takes Medical Leave of Absence May 24, 2023 From CytoDyn Inc. Via GlobeNewswire CytoDyn to Hold Webcast to Provide a Company Update April 05, 2023 From CytoDyn Inc. Via GlobeNewswire Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December January 17, 2023 Via Benzinga CytoDyn to Hold Webcast to Discuss the Performance of Leronlimab in Clinical Trials and Recent Charges Against Former CEO December 23, 2022 From CytoDyn Inc. Via GlobeNewswire OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes December 13, 2022 Via Benzinga CytoDyn to Host R&D Update on Wednesday, December 7, 2022 November 22, 2022 From CytoDyn Inc. Via GlobeNewswire CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues October 28, 2022 From CytoDyn Inc. Via GlobeNewswire Most Active On The OTC Markets In September – A Look Back As October Comes To A Close October 27, 2022 Via Benzinga CytoDyn Announces Appointment of Additional Directors with Industry Experience October 20, 2022 From CytoDyn Inc. Via GlobeNewswire OTC Markets' Most Active Securities Sees A Shake-up In July August 16, 2022 Via Benzinga CYTODYN ALERT: Bragar Eagel & Squire, P.C. is Investigating CytoDyn, Inc. on Behalf of CytoDyn Stockholders and Encourages Investors to Contact the Firm August 11, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire CYTODYN ALERT: Bragar Eagel & Squire, P.C. is Investigating CytoDyn, Inc. on Behalf of CytoDyn Stockholders and Encourages Investors to Contact the Firm August 10, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month August 05, 2022 Via Benzinga Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June July 18, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
